Sign in to purchase
VANGUARD® B ORAL is the Bordetella bronchiseptica vaccine that helps provide protection by stimulating a mucosal immune response.
"We have given over 500 doses of the new VANGUARD® B Oral without any complications. The exceptional palatability and ease of administration is why it's our first choice for a Bordetella bronchiseptica vaccine."
Dr. Lowell O. Henderson,
Memorial Vet Pet Care Hospital, Houston, Texas
For vaccination of healthy dogs 8 weeks of age or older as an aid in preventing canine infectious tracheobronchitis (Kennel Cough) caused by Bordetella bronchiseptica.
Administer a single 1 mL dose orally into the buccal pouch
Annual revaccination with a single dose is recommended
The 1 mL dose may be administered with a syringe or a syringe-free applicator (to reduce the risk of accidental injections), providing a smooth exam room experience for veterinary staff, patients and pet owners.
Canine Infectious Respiratory Disease (CIRD)
CIRD is caused by many bacteria and viruses. Bordetella bronchiseptica is a commonly encountered bacterial pathogen in the disease complex that often leads to clinical signs of respiratory disease in dogs.
Convenient choices for vaccinating against the primary CIRD pathogen helps you PREVENT THE PREVENTABLE.
Efficacy and Safety Studies
Dogs were evaluated for clinical signs of respiratory disease including cough, nasal discharge, sneeze, ocular discharge, retch, depression, respiration and fever.
The vaccine significantly reduced coughing, p<0.0085 in comparison to the controls
Challenge resulted in cough in 75% of the controls, indicating challenge was successful
100% of control dogs coughed in multiple (not necessarily consecutive) periods after the challenge
No adverse events were noted during the study
Out of 321 client-owned dogs enrolled, ONE was reported to have had a brief self-limiting episode of vomiting within the 15-minute post-vaccination period.
Datz C. Bordetella infections in dogs and cats: pathogenesis, clinical signs, and diagnosis. Compend Contin Educ Pract Vet. 2003a;25(12):896-901.
Datz C. Bordetella infections in dogs and cats: pathogenesis, clinical signs, and diagnosis. Compend Contin Educ Pract Vet. 2003b;25(12):902-914.
Ford RB. Bordetella bronchiseptica: beyond kennel cough. In: Bonagura JD, Twedt DC, eds. Kirk’s Current Veterinary Therapy XIV. St. Louis, MO: WB Saunders-Elsevier; 2009:646-649.
Chalker VJ, Toomey C, Opperman S, et al. Respiratory disease in kennelled dogs: serological responses to Bordetella bronchiseptica lipopolysaccharide do not correlate with bacterial isolation or clinical respiratory symptoms. Clin Diagn Lab Immunol. 2003;10(3):352-356.
Keil DJ, Fenwick B. Role of Bordetella bronchiseptica in infectious tracheobronchitis in dogs. J Am Vet Med Assoc. 1998;212(2):200-207.
Ford RB. Canine infectious tracheobronchitis. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. 3rd ed. St. Louis, MO: WB Saunders-Elsevier; 2006:54-61.
Data on file, Study Report No. B862R-US-14-129, Zoetis LLC.
Data on file, Study Report No. B961R-US-14-167, Zoetis LLC.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless oterwise noted.
Zoetis Inc. All rights reserved. SAB-00310
- Belgium (French)
- Belgium (Dutch)
- Costa Rica
- Czech Republic
- New Zealand
- South Africa
- South Korea
- United Kingdom
- United States